Translational Study of Molecular Classification of Relapsed/Refractory Diffuse Large B-cell Lymphoma

CompletedOBSERVATIONAL
Enrollment

324

Participants

Timeline

Start Date

April 14, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

March 30, 2022

Conditions
Lymphoma, Large B-Cell, DiffuseGene Expression Profiling
Interventions
DIAGNOSTIC_TEST

Gene expression profile

"Diagnostic Test:~The Canhelp-COO Assay (Canhelp Genomics CO., Ltd) for differentiating COO subtypes using gene expression analysis by real-time PCR (RT-PCR)"

Trial Locations (1)

200032

Yian Zhang, Shanghai

All Listed Sponsors
collaborator

Wuxi People's Hospital

OTHER

collaborator

Shanghai Minhang Central Hospital

OTHER

lead

Shanghai Zhongshan Hospital

OTHER